Summary
This Form 8-K filing from HCA Holdings, Inc. (now HCA Healthcare, Inc.) on December 14, 2012, details a significant secondary offering of the company's common stock. The company and selling shareholders entered into an Underwriting Agreement with Morgan Stanley & Co. LLC for the sale of 32,000,000 shares of common stock. This offering was conducted via a Form S-3 registration statement and prospectus supplement, indicating a substantial transaction involving existing shareholders looking to divest a portion of their holdings. For investors, this filing signals an active market for HCA's stock and the intention of significant shareholders to sell. The offering price of $33.00 per share provides a benchmark for the stock's valuation at that time. While HCA itself is not selling new shares (all shares are from Selling Shareholders), such a large offering can influence stock price due to increased supply in the market. Investors should consider the implications for liquidity and potential price movements following this transaction.
Key Highlights
- 1HCA Holdings, Inc. entered into an Underwriting Agreement on December 10, 2012, for a secondary stock offering.
- 2The offering involved the sale of 32,000,000 shares of common stock by selling shareholders.
- 3Morgan Stanley & Co. LLC acted as the sole underwriter for this transaction.
- 4The shares were purchased by the underwriter at a price of $33.00 per share.
- 5The transaction was completed on December 14, 2012.
- 6The offering was conducted under a Form S-3 registration statement, indicating an established reporting company.
- 7All shares sold in the offering originated from existing shareholders, not from the company's treasury or new issuance.